세계의 주기성 월경 과다 시장 보고서(2025년)

Cyclic heavy menstrual bleeding is a medical condition characterized by abnormally heavy and prolonged menstrual periods that occur regularly on a monthly cycle. It can result from a variety of factors, including hormonal imbalances, uterine fibroids, polyps, adenomyosis (a condition in which the uterine lining grows into the muscular wall of the uterus), certain medications, or underlying medical conditions. The treatment for this condition involves employing a range of medical strategies and interventions to effectively manage its symptoms and associated complications.

The primary types of cyclic heavy menstrual bleeding include polymenorrhea, oligomenorrhea, and metrorrhagia. Polymenorrhea is a medical term used to describe menstrual cycle irregularities where a woman experiences menstrual periods more frequently than the typical cycle length of approximately 21 to 35 days. Treatment options encompass medications, hormonal therapy, and surgical procedures, with various methods of administration such as oral and parenteral. These treatments are utilized by diverse end-users, including hospitals, home-based care, specialty clinics, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The cyclic heavy menstrual bleeding market research report is one of a series of new reports from The Business Research Company that provides cyclic heavy menstrual bleeding market statistics, including cyclic heavy menstrual bleeding industry global market size, regional shares, competitors with a cyclic heavy menstrual bleeding market share, detailed cyclic heavy menstrual bleeding market segments, market trends and opportunities and any further data you may need to thrive in the cyclic heavy menstrual bleeding industry. This cyclic heavy menstrual bleeding market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cyclic heavy menstrual bleeding market size has grown strongly in recent years. It will grow from $42.97 billion in 2024 to $45.7 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to aging population, raise awareness about menstrual health, rising disposable incomes, government initiatives.

The cyclic heavy menstrual bleeding market size is expected to see strong growth in the next few years. It will grow to $58.1 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to growing female population, rising prevalence of obesity, increasing access to healthcare, growing popularity of biosimilars, increasing demand for preventive treatments. Major trends in the forecast period include medical advancements, minimally invasive procedures, nutritional approaches, eco-friendly menstrual products.

The forecast of 6.2% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose a significant challenge for the U.S. by restricting access to specialized endometrial ablation devices and hormonal IUDs imported from Finland and the Netherlands, potentially prolonging gynecological suffering and increasing women's health costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The escalating incidence of uterine fibroids and polyps is anticipated to serve as a catalyst for the expansion of the cyclic heavy menstrual bleeding market in the foreseeable future. Uterine fibroids and uterine polyps are common noncancerous growths that can develop within the uterus (womb) of women. Treatment for these conditions plays a pivotal role in reducing blood loss, regulating the menstrual cycle, preventing complications, and improving the emotional well-being of individuals grappling with menstrual disorders. For instance, as of March 2022, data published in Frontiers, a journal based in Switzerland, reported the results of a survey conducted in the United States among 1,346 randomly selected women aged 35 to 49. The survey, which relied on self-reporting, revealed a 60% incidence of uterine fibroids by age 35 among African-American women, which increased to over 80% by age 50. In contrast, Caucasian women in the same study exhibited an incidence of 40% by age 35, escalating to nearly 70% by age 50. Hence, the increasing prevalence of uterine fibroids and polyps is a driving force behind the growth of the cyclic heavy menstrual bleeding market.

The increasing awareness regarding menstrual health and the implementation of government initiatives are poised to act as driving forces for the growth of the cyclic heavy menstrual bleeding market in the foreseeable future. Menstrual health awareness encompasses the knowledge, understanding, and acknowledgment of various aspects related to the menstrual cycle, reproductive health, and the physical and emotional well-being of individuals experiencing menstruation. It aims to address social taboos, dispel myths and misconceptions surrounding menstruation, and empower individuals to manage their menstrual health confidently, with dignity, and access to essential resources. For instance, as of May 2022, the World Bank, a US-based financial institution, reported that the government of Ghana introduced The GAMA Sanitation and Water Project. This initiative included a comprehensive qualitative study to explore the effects of Menstrual Health Management (MHM) interventions in schools on the educational engagement of adolescent girls. The project involved the construction of sanitation facilities in over 260 schools throughout the Greater Accra Metropolitan Area. These facilities featured separate and secure toilets and changing rooms for girls, equipped with locks on doors, hygienic and safe disposal areas for used sanitary products, and handwashing facilities. Consequently, the rising awareness of menstrual health and government initiatives are key drivers behind the growth of the cyclic heavy menstrual bleeding market.

Major companies in the cyclic heavy menstrual bleeding market are focusing on developing innovative products, such as menstrual health solutions, to support and enhance menstrual well-being. These menstrual health products are designed to manage menstrual flow and maintain hygiene during menstruation, including items like sanitary pads, tampons, and menstrual cups. They provide comfort, convenience, and protection during the menstrual cycle. For example, in August 2022, Looni, a US-based women's health company, introduced its first menstrual health product, the Balance Beam Mood Complex. This daily supplement is designed to support hormone and neurotransmitter balance, helping reduce mood swings and menstrual discomfort. Priced at $39.99 for a 30-day supply, it contains bioavailable vitamins, minerals, nootropics, and adaptogens.

In October 2022, Unified Women's Healthcare, a healthcare company based in the United States specializing in women's healthcare treatment, completed the acquisition of Gennev for an undisclosed sum. This strategic move by Unified Women's Healthcare is aimed at enhancing its women's healthcare portfolio to offer improved healthcare outcomes and a superior patient experience across all stages of a woman's healthcare journey. Gennev, also based in the United States, is a company dedicated to providing feminine care services, offering a range of treatments that empower women to actively manage their health during and after menopause. This acquisition serves as a pivotal step in strengthening women's healthcare services.

Major companies operating in the cyclic heavy menstrual bleeding market are Pfizer Inc., Merck and Co. Inc., Novartis AG, Abbott Laboratories, GlaxoSmithKline PLC, Medtronic PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Reckitt Benckiser Group PLC, Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies Inc., Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Limited, Cipla Limited, Ferring B.V., Amneal Pharmaceuticals LLC, Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd.

North America was the largest region in the cyclic menstrual bleeding market in 2024. The regions covered in cyclic heavy menstrual bleeding report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cyclic heavy menstrual bleeding market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cyclic heavy menstrual bleeding market consists of revenues earned by entities by provide diagnostic testing, treatment planning and non-hormonal medications. The market value includes the value of related goods sold by the service provider or included within the service offering. The cyclic heavy menstrual bleeding market also includes sales of sanitary products, hormonal contraceptives, tranexamic acid and nonsteroidal anti-inflammatory drugs (NSAIDs). Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cyclic Heavy Menstrual Bleeding Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cyclic heavy menstrual bleeding market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cyclic heavy menstrual bleeding ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cyclic heavy menstrual bleeding market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Polymenorrhea; Oligomenorrhea; Metrorrhagia
• 2) By Treatment Type: Medication; Hormonal Therapy; Surgery
• 3) By Route of Administration: Oral; Parenteral
• 4) By End-Users: Hospitals; Homecare; Specialty Clinics; Other End-Users
• Subsegments:
• 1) By Polymenorrhea: Hormonal Treatments; Non-Hormonal Treatments; Surgical Interventions
• 2) By Oligomenorrhea: Hormonal Treatments; Lifestyle Modifications; Medication for Underlying Conditions
• 3) By Metrorrhagia: Hormonal Treatments; Non-Hormonal Medications; Surgical Options
• Companies Mentioned: Pfizer Inc.; Merck and Co. Inc.; Novartis AG; Abbott Laboratories; GlaxoSmithKline Plc; Medtronic Plc; Takeda Pharmaceutical Company Limited; Eli Lilly and Company; Amgen Inc.; Boehringer Ingelheim International GmbH; Reckitt Benckiser Group Plc; Teva Pharmaceutical Industries Ltd.; Mylan N.V.; Bausch Health Companies Inc.; Eisai Co. Ltd.; Sun Pharmaceutical Industries Ltd.; Perrigo Company PLC; Dr. Reddy's Laboratories Ltd.; Aurobindo Pharma Limited; Cipla Limited; Ferring B.V.; Amneal Pharmaceuticals LLC; Zydus Lifesciences Ltd.; Lupin Limited; Torrent Pharmaceuticals Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cyclic Heavy Menstrual Bleeding Market Characteristics

3. Cyclic Heavy Menstrual Bleeding Market Trends And Strategies

4. Cyclic Heavy Menstrual Bleeding Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cyclic Heavy Menstrual Bleeding Growth Analysis And Strategic Analysis Framework

• 5.1. Global Cyclic Heavy Menstrual Bleeding PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Cyclic Heavy Menstrual Bleeding Market Growth Rate Analysis
• 5.4. Global Cyclic Heavy Menstrual Bleeding Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Cyclic Heavy Menstrual Bleeding Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Cyclic Heavy Menstrual Bleeding Total Addressable Market (TAM)

6. Cyclic Heavy Menstrual Bleeding Market Segmentation

• 6.1. Global Cyclic Heavy Menstrual Bleeding Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polymenorrhea
• Oligomenorrhea
• Metrorrhagia
• 6.2. Global Cyclic Heavy Menstrual Bleeding Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medication
• Hormonal Therapy
• Surgery
• 6.3. Global Cyclic Heavy Menstrual Bleeding Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Parenteral
• 6.4. Global Cyclic Heavy Menstrual Bleeding Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Homecare
• Specialty Clinics
• Other End-Users
• 6.5. Global Cyclic Heavy Menstrual Bleeding Market, Sub-Segmentation Of Polymenorrhea, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hormonal Treatments
• Non-Hormonal Treatments
• Surgical Interventions
• 6.6. Global Cyclic Heavy Menstrual Bleeding Market, Sub-Segmentation Of Oligomenorrhea, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hormonal Treatments
• Lifestyle Modifications
• Medication for Underlying Conditions
• 6.7. Global Cyclic Heavy Menstrual Bleeding Market, Sub-Segmentation Of Metrorrhagia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hormonal Treatments
• Non-Hormonal Medications
• Surgical Options

7. Cyclic Heavy Menstrual Bleeding Market Regional And Country Analysis

• 7.1. Global Cyclic Heavy Menstrual Bleeding Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Cyclic Heavy Menstrual Bleeding Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cyclic Heavy Menstrual Bleeding Market

• 8.1. Asia-Pacific Cyclic Heavy Menstrual Bleeding Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cyclic Heavy Menstrual Bleeding Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Cyclic Heavy Menstrual Bleeding Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Cyclic Heavy Menstrual Bleeding Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cyclic Heavy Menstrual Bleeding Market

• 9.1. China Cyclic Heavy Menstrual Bleeding Market Overview
• 9.2. China Cyclic Heavy Menstrual Bleeding Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Cyclic Heavy Menstrual Bleeding Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Cyclic Heavy Menstrual Bleeding Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cyclic Heavy Menstrual Bleeding Market

• 10.1. India Cyclic Heavy Menstrual Bleeding Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Cyclic Heavy Menstrual Bleeding Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Cyclic Heavy Menstrual Bleeding Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cyclic Heavy Menstrual Bleeding Market

• 11.1. Japan Cyclic Heavy Menstrual Bleeding Market Overview
• 11.2. Japan Cyclic Heavy Menstrual Bleeding Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Cyclic Heavy Menstrual Bleeding Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Cyclic Heavy Menstrual Bleeding Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cyclic Heavy Menstrual Bleeding Market

• 12.1. Australia Cyclic Heavy Menstrual Bleeding Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Cyclic Heavy Menstrual Bleeding Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Cyclic Heavy Menstrual Bleeding Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cyclic Heavy Menstrual Bleeding Market

• 13.1. Indonesia Cyclic Heavy Menstrual Bleeding Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Cyclic Heavy Menstrual Bleeding Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Cyclic Heavy Menstrual Bleeding Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cyclic Heavy Menstrual Bleeding Market

• 14.1. South Korea Cyclic Heavy Menstrual Bleeding Market Overview
• 14.2. South Korea Cyclic Heavy Menstrual Bleeding Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Cyclic Heavy Menstrual Bleeding Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Cyclic Heavy Menstrual Bleeding Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cyclic Heavy Menstrual Bleeding Market

• 15.1. Western Europe Cyclic Heavy Menstrual Bleeding Market Overview
• 15.2. Western Europe Cyclic Heavy Menstrual Bleeding Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Cyclic Heavy Menstrual Bleeding Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Cyclic Heavy Menstrual Bleeding Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cyclic Heavy Menstrual Bleeding Market

• 16.1. UK Cyclic Heavy Menstrual Bleeding Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Cyclic Heavy Menstrual Bleeding Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Cyclic Heavy Menstrual Bleeding Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cyclic Heavy Menstrual Bleeding Market

• 17.1. Germany Cyclic Heavy Menstrual Bleeding Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Cyclic Heavy Menstrual Bleeding Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Cyclic Heavy Menstrual Bleeding Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cyclic Heavy Menstrual Bleeding Market

• 18.1. France Cyclic Heavy Menstrual Bleeding Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Cyclic Heavy Menstrual Bleeding Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Cyclic Heavy Menstrual Bleeding Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cyclic Heavy Menstrual Bleeding Market

• 19.1. Italy Cyclic Heavy Menstrual Bleeding Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Cyclic Heavy Menstrual Bleeding Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Cyclic Heavy Menstrual Bleeding Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cyclic Heavy Menstrual Bleeding Market

• 20.1. Spain Cyclic Heavy Menstrual Bleeding Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Cyclic Heavy Menstrual Bleeding Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Cyclic Heavy Menstrual Bleeding Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cyclic Heavy Menstrual Bleeding Market

• 21.1. Eastern Europe Cyclic Heavy Menstrual Bleeding Market Overview
• 21.2. Eastern Europe Cyclic Heavy Menstrual Bleeding Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Cyclic Heavy Menstrual Bleeding Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Cyclic Heavy Menstrual Bleeding Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cyclic Heavy Menstrual Bleeding Market

• 22.1. Russia Cyclic Heavy Menstrual Bleeding Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Cyclic Heavy Menstrual Bleeding Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Cyclic Heavy Menstrual Bleeding Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cyclic Heavy Menstrual Bleeding Market

• 23.1. North America Cyclic Heavy Menstrual Bleeding Market Overview
• 23.2. North America Cyclic Heavy Menstrual Bleeding Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Cyclic Heavy Menstrual Bleeding Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Cyclic Heavy Menstrual Bleeding Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cyclic Heavy Menstrual Bleeding Market

• 24.1. USA Cyclic Heavy Menstrual Bleeding Market Overview
• 24.2. USA Cyclic Heavy Menstrual Bleeding Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Cyclic Heavy Menstrual Bleeding Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Cyclic Heavy Menstrual Bleeding Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cyclic Heavy Menstrual Bleeding Market

• 25.1. Canada Cyclic Heavy Menstrual Bleeding Market Overview
• 25.2. Canada Cyclic Heavy Menstrual Bleeding Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Cyclic Heavy Menstrual Bleeding Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Cyclic Heavy Menstrual Bleeding Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cyclic Heavy Menstrual Bleeding Market

• 26.1. South America Cyclic Heavy Menstrual Bleeding Market Overview
• 26.2. South America Cyclic Heavy Menstrual Bleeding Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Cyclic Heavy Menstrual Bleeding Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Cyclic Heavy Menstrual Bleeding Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cyclic Heavy Menstrual Bleeding Market

• 27.1. Brazil Cyclic Heavy Menstrual Bleeding Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Cyclic Heavy Menstrual Bleeding Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Cyclic Heavy Menstrual Bleeding Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cyclic Heavy Menstrual Bleeding Market

• 28.1. Middle East Cyclic Heavy Menstrual Bleeding Market Overview
• 28.2. Middle East Cyclic Heavy Menstrual Bleeding Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Cyclic Heavy Menstrual Bleeding Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Cyclic Heavy Menstrual Bleeding Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cyclic Heavy Menstrual Bleeding Market

• 29.1. Africa Cyclic Heavy Menstrual Bleeding Market Overview
• 29.2. Africa Cyclic Heavy Menstrual Bleeding Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Cyclic Heavy Menstrual Bleeding Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Cyclic Heavy Menstrual Bleeding Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cyclic Heavy Menstrual Bleeding Market Competitive Landscape And Company Profiles

• 30.1. Cyclic Heavy Menstrual Bleeding Market Competitive Landscape
• 30.2. Cyclic Heavy Menstrual Bleeding Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. GlaxoSmithKline Plc Overview, Products and Services, Strategy and Financial Analysis

31. Cyclic Heavy Menstrual Bleeding Market Other Major And Innovative Companies

• 31.1. Medtronic Plc
• 31.2. Takeda Pharmaceutical Company Limited
• 31.3. Eli Lilly and Company
• 31.4. Amgen Inc.
• 31.5. Boehringer Ingelheim International GmbH
• 31.6. Reckitt Benckiser Group Plc
• 31.7. Teva Pharmaceutical Industries Ltd.
• 31.8. Mylan N.V.
• 31.9. Bausch Health Companies Inc.
• 31.10. Eisai Co. Ltd.
• 31.11. Sun Pharmaceutical Industries Ltd.
• 31.12. Perrigo Company PLC
• 31.13. Dr. Reddy's Laboratories Ltd.
• 31.14. Aurobindo Pharma Limited
• 31.15. Cipla Limited

32. Global Cyclic Heavy Menstrual Bleeding Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cyclic Heavy Menstrual Bleeding Market

34. Recent Developments In The Cyclic Heavy Menstrual Bleeding Market

35. Cyclic Heavy Menstrual Bleeding Market High Potential Countries, Segments and Strategies

• 35.1 Cyclic Heavy Menstrual Bleeding Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Cyclic Heavy Menstrual Bleeding Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Cyclic Heavy Menstrual Bleeding Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer